Not Signed In - Shire Bioequivalence Study Results Of SPD465, Investigational Drug For Adults With ADHD
Thu, 23 Nov 2006 09:00 AM EST
... Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults for up to 16 [click link for full article] ...
Related Topics
- Older Adults
- ADHD
- Drug Safety
- Guanfacine
- Prescription Drugs
- Urinalysis
- Drug Side Effects
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Galantamine
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Brain tumor - adults
- Wellness Screening: Adults
- Nephrotic Syndrome in Adults
- Kidney Stones in Adults
- Radiation Studies
- Urinary Tract Infections in Adults
- Cost of Falls Among Older Adults
email this page
print this page
bookmark this page
feedback on this page
